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Abstract
Trans-splicing is a common phenomenon in nematodes and kinetoplastids, and it has also been reported in other
organisms, including humans. Up to now, all in silico strategies to find evidence of trans-splicing in humans have
required that the candidate sequences follow the consensus splicing site rules (spliceosome-mediated mechanism).
However, this criterion is not supported by the best human experimental evidence, which, except in a single case,
do not follow canonical splicing sites. Moreover, recent findings describe a novel alternative tRNA mediated trans-
splicing mechanism, which prescinds the spliceosome machinery. In order to answer the question, ‘Are there hybrid
mRNAs in sequence databanks, whose characteristics resemble those of the best human experimental evidence?’,
we have developed a methodology that successfully identified 16 hybrid mRNAs which might be instances of inter-
chromosomal trans-splicing. Each hybrid mRNA is formed by a trans-spliced region (TSR), which was successfully
mapped either onto known genes or onto a human endogenous retrovirus (HERV-K) transcript which supports
their transcription. The existence of these hybrid mRNAs indicates that trans-splicing may be more widespread
than believed. Furthermore, non-canonical splice site patterns suggest that infrequent splicing sites may occur
under special conditions, or that an alternative trans-splicing mechanism is involved. Finally, our candidates are
supposedly from normal tissue, and a recent study has reported that trans-splicing may occur not only in malignant
tissues, but in normal tissues as well. Our methodology can be applied to 50 -UTR, coding sequences and 30 -UTR
in order to find new candidates for a posteriori experimental confirmation.
Keywords: bioinformatics; inter-chromosomal trans-splicing; non-canonical splicing sites; tRNA-mediated trans-splicing;
inverted repeats
BACKGROUND
Trans-splicing is an unusual form of RNA splicing,
where distinct pre-mRNA transcripts contribute to
a single mRNA formation. Although less frequent
and less well understood than cis-splicing, trans-
splicing has gained momentum owing to its promis-
ing applications. For example, trans-splicing has
been applied to correct genetic defects in some
species without the unwanted side-effects of
unregulated expression of the target genes [1],
and it has been used in a variety of human health
applications reported in the specialized literature
[2–10].
In 1993, Bonen [11] proposed two trans-splicing
categories: the spliced leader (SL), and the discontinuous
group II intron. The first type is common in organisms
such as nematodes [12] and kinetoplastids [13],
where a short leader sequence is trans-spliced into
an untranslated mRNA 50 region (50UTR). The
other type is found in plants, algal chloroplasts
and plant mitochondria, and involves the joining of
independently transcribed coding sequences. Both
categories follow consensus splicing site rules
which resemble conventional spliceosome-mediated
cis-splicing. In the last few years, evidence in other
organisms has shown that, although a rare
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phenomenon, trans-splicing may be more widespread
than believed.
Trans-splicing has been reported in Drosophila by
Labrador et al. [14] and by Horiuchi and Aigaki [15],
who observed that the trans-splicing phenomenon
occurred after independently transcribed pre-
mRNAs formed double-stranded RNA through
complementary sequences in the mod(mdg4) gene.
A similar mechanism [16] has been described,
where the directed repetitive sequences that flanked
two distinct genes approximated their respective
pre-mRNAs in order to accomplish a trans-splicing
event. Robertson et al. [17] found the first, and, to
the best of our knowledge, only instance of trans-
splicing in mosquitoes involving an internal gene’s
exons from distinct chromosomal loci.
Trans-splicing was reported in mammalian cells
for the first time in rat liver [18]. Rigatti et al. [19]
analyzed two rat genes that have tandem repeated
exons, and, as the tandem exons were not observed
in the respective genomic region, the authors pro-
posed trans-splicing as a possible explanation.
Evidence of intrachromosomal trans-splicing has
been reported in cattle [20]. It is worth noting that
heterologous mRNA hybrids were generated by
mRNA trans-splicing, or the transcription of long
mRNA across neighboring loci. It is interesting
that independent work [21] has revealed that, in
fact, the proximity of different transcripts can facili-
tate the occurrence of trans-splicing.
The diversity of trans-splicing phenomena in
mammals is frequently associated with cancer, an
association that has been studied by Chen et al.
[22], who analyzed the structure of abnormal MYC
mRNA genes related to tumoral cells, and con-
cluded that the anomalous transcripts are usually
generated by trans-splicing. Hahn et al. [23], using
an EST library, found several fused genes from
chromosome rearrangement, and unexpectedly,
identified some cases that might be evidence of
trans-splicing in normal tissues.
Canonical splicing sites worthy of note have
been observed in all the studies mentioned. Rather
interestingly, however, all but one reported that
human experimental evidence fails to follow canon-
ical splicing sites [13–16,24]. This may be explained
either by the occurrence of infrequent splicing sites
or by the existence of non-spliceosome-mediated
trans-splicing mechanisms. The first possibility is
plausible because trans-splicing is a rare phenomenon,
and it is not unreasonable to conceive of the
occurrence of non-canonical splicing sites, as has
happened elsewhere [25]. The second possibility
is plausible because the hybrid mRNAs might be
the result of an alternative RNA processing mecha-
nism which does not use the spliceosome machinery,
such as the recently reported tRNA-mediated trans-
splicing [26,27]. In this new mechanism, the hybrid
mRNA is generated by trans-splicing two comple-
mentary pre-tRNA halves joined to two different
pre-mRNAs. The authors speculate that ‘another
feasible way to achieve trans-splicing of mRNAs
by tRNA endonuclease is to exploit the vast reper-
toire of repetitive sequences present in eukaryotic
organisms’. Remembering that Short Interspersed
Nuclear Elements (SINE) are related to tRNA
genes or other RNA Polymerase III-transcribed
genes, and that Alu elements constitute the most
abundant family of short repeats (SINE), Alu ele-
ments may play a major role in trans-splicing in
humans and other primates.
The first two examples of human experimental
evidence have the same hybrid mRNA pattern:
part of their 50UTR came from one chromosome
and the remaining sequence from another. This
trans-splicing pattern resembles that of the SL cate-
gory, although the trans-spliced sequence is not
usually ‘short’ and, as already mentioned, neither
example follows the splicing site rules, which
means that they can not be classified as SL category.
The first human interchromosomal trans-splicing
evidence was reported back in 1997 [28]. A trun-
cated isoform of the Ca2þ/calmodulin-dependent
protein kinase II (CaM kinase II) expressed in the
human islets of Langerhans was experimentally
demonstrated to be a hybrid mRNA formed from
one transcript belonging to chromosome 10 and
another from chromosome 18. The second example
of experimental evidence was the human cholesterol
acyltransferase-1 (ACAT-1) hybrid mRNA [29].
Its 50UTR was mapped onto chromosome 7, while
the remaining sequence was mapped onto chromo-
some 1. Its interesting characteristic was the presence
of an unusually long 50UTR with 1396 base pairs
(bp). Note that the average 50UTR length ranges
from 100 to 200 bp [30]. Just as in the preceding
case, there were no canonical splicing sites. To rule
out the possibility of this hybrid mRNA being
a ligation artifact produced during cDNA synthesis
in vitro, RT–PCR experiments were performed, and
the results were consistent with the trans-splicing
hypothesis.


















Projects aiming to find new genes and study their
expression profiles, or identify new genetic markers
such as a single nucleotide polymorphism (SNP),
have produced a huge number of publicly available
human transcript sequences. The development of
novel efficient bioinformatics algorithms has made
possible in silico strategies to search for human trans-
splicing evidence in extremely large databases. The
In Silico Trans-splicing Retrieval SystemçISTReS [31]
was proposed in order to meet this challenge. Its
methodology is quite simple. First, the cDNA data-
base chosen was mapped onto the human genome
using BLAST. Then, only those hits that satisfied
some predefined criteria were retained. One of
its most restrictive criteria was to impose consensus
splicing site rules. This criterion is quite controver-
sial, because it plainly excludes both examples of
human experimental inter-chromosomal trans-
splicing evidence mentioned above. Nevertheless,
the ISTReS running over the NCBI RefSeq data-
bank found 55 hybrid mRNAs, of which only
21 were from normal tissues. The remaining 34
hybrid mRNAs were from malignant tissues, and it
is known that genomic rearrangement frequently
occurs in malignant tissues [32]. This last explanation
seems to be more reasonable than trans-splicing.
Therefore, ISTReS found 21 hybrid mRNAs that
might be real instances of human trans-splicing
that follow consensus splicing site rules; however,
ISTReS misses those instances that do not.
In 2006, using 5 992 495 human-expressed
sequence tags (EST) and ad hoc bioinformatics algo-
rithms, several examples of exon repetition, exon
scrambling and human trans-splicing were reported
[33]. However, in this work, all 15 trans-splicing
instances were from cancerous tissue (amelanotic
melanoma), which, as the authors recognize, weak-
ens the trans-splicing hypothesis.
These bioinformatics initiatives have proved to be
sound and can be successfully applied to search for
additional human trans-splicing evidence. Their main
challenges are the huge number of sequences and the
rarity of the trans-splicing phenomenon that compli-
cates the problem. For this reason, some filtering
strategy is unavoidable. Nevertheless, the filtering
criteria should incorporate what we have learned
so far from the experimental evidence. There are
three main lessons, which can be summarized as
follows. First, the focus should be on interchromo-
somal trans-splicing, because the best human experi-
mental evidence belongs to this category. Second,
hybrid mRNA is usually formed by a 50UTR
(or part of it) from one chromosome and the remain-
ing sequence from another. Third, the occurrence of
non-canonical splicing sites means that rare splicing
sites may occur by chance, or might be the result
of a non-spliceosome-mediated trans-splicing mech-
anism. None of the human trans-splicing candidate
sequences reported so far satisfy those criteria
simultaneously.
This work aims to show how to search for hybrid
mRNAs in publicly available databases, the charac-
teristics of which resemble those of the best
human experimental trans-splicing evidence. It is
worth noting that the trans-splicing fusion point
may occur in coding sequences (CDS) and 30UTR,
and our methodology is intended to deal with these
cases as well.
MATERIALSANDMETHODS
In the following paragraphs, we describe our in silico
methodology for searching for human trans-splicing
evidence that considers the three lessons mentioned
above. Considering that the supposed novel inter-
chromosomal trans-splicing mechanism is still under
investigation, we do not claim that our methodology
can identify all categories of interchromosomal trans-
splicing, although it successfully finds some instances,
the characteristics of which are similar to those
reported in experiments.
Database
The choice of database is no easy task, as there are
plenty of options available. Each database has its
own characteristics; consequently, it is critical to
state which characteristics are most relevant to our
point of view. Definitely, the transcript structure
information, i.e. 50UTR–CDS–30UTR, is funda-
mental. Therefore, we decided to use a curated
full-length cDNA (FLcDNA) library instead of an
EST library, the sequences of which are shorter
and significantly more redundant.
In 2004, an international collaborative project
[34] built an integrated database of human genes
and transcripts, called the H-Invitational Database
(H-InvDB) (http://www.h-invitational.jp), which
fully satisfied our criteria. It has a unique set of
high-quality cDNA clones with curated annotation.
H-InvDB release 5.0, based on human genome build
36.3, has 187 156 FLcDNA sequences. However,
only 137 315 sequences have complete information
about 50UTR, CDS and 30UTR regions. Moreover,


















the malignant tissues impose some result interpreta-
tion difficulties. For this reason, we removed all the
sequences with a tissue origin positively identified as
comprising malignant cells. After this preprocessing
filtering, we built our own database of 113 202
sequences.
Filtering strategy
Our filtering strategy aims to minimize computa-
tional effort by reducing the number of sequences.
Nonetheless, to properly define the filtering criteria,
it is necessary to have a clear idea of what we are
looking for. What are the characteristics that distin-
guish the sequences that could constitute human
trans-splicing evidence? We have already mentioned
that, considering the experimental evidence, the
sequences we are looking for are hybrid mRNAs.
More specifically, their 50UTRs, or parts of them,
are mapped onto one chromosome, while their
CDS and 30UTR are found in a distinct chromo-
some. In other words, we are looking for a particular
trans-splicing type: interchromosomal. We do not
impose splicing site rules.
Trans-splicing candidates
Our methodology is detailed in Figure 1. Initially,
the H-InvDB transcripts (FLcDNA) are filtered
(HInvFilter) to create a FLcDNA_FILT fasta file
containing only those sequences with complete
50UTR, CDS and 30UTR information, collected
from tissue cells without malignant labels. Next,
we created three different files FLcDNA_FILT_
5UTR, FLcDNA_FILT_CDS and FLcDNA_
FILT_3UTR for 50UTR, CDS and 30UTR
sequences, respectively. Using BLAST, we mapped
all the 50UTR, CDS and 30UTR sequences onto
human genome build 36.3 (BLAST parameters
are detailed in Figure 1 and double-checked
using BLAT [35]). The result was saved in
three XML alignment files. The XML file
corresponding to 50UTR was cross-matched
(GeneAlignmentAnalyser) to the CDS and the
30UTR XML files. We retained only those
sequences where TSRs were located in only a
single chromosome and nowhere else, in order
to avoid ambiguities in interpretation. Only
these hybrid mRNAs were stored in the TransSpl
file.
Figure 1: Filtering and trans-splicing detection methodology fluxogram. There are four steps in the methodology,
each of which is associated with an application: HInvFilter, SplitSequences, NCBI-BLAST and
GeneAlignmentAnalyser.



















We found 16 hybrid mRNAs (Table 1), the
characteristics of which resemble those of the
best human experimental trans-splicing evidence. As
described in the Materials and Methods section, in
order to avoid interpretational ambiguities, all the
candidate hybrid mRNAs had their TSRs mapped
onto only one single chromosome locus and
nowhere else. Although the second case of experi-
mental evidence suggested looking for transcripts
with exceptionally long 50UTR (like ACAT-1
50UTR with 1.396 bp), our methodology found
four candidate sequences with 50UTR shorter than
400 bp.
Remarkably, there is no intersection between
our candidate list and the ISTReS’. The cDNA data-
base differences may be part of the explanation.
There is, however, another reason that seems to
be more significant: we did not impose canonical
splice sites, and, interestingly enough, none of
our candidate sequences follows them (Table 2).
We speculate that this is related to the fact that
our methodology was designed to look for a very
specific trans-splicing category, i.e. interchromosomal
trans-splicing, where the TSR belongs exclusively
to 50UTR. Perhaps this type of trans-splicing does
not make use of canonical splicing sites or spliceo-
some machinery.
We double-checked the sequence quality with
regard to external contamination, and found no
vectorial, mitochondrial, or bacterial contamination.
Unfortunately, although H-InvDB is a highly
curated database, we cannot exclude the possibility
that some hybrid mRNAs were produced by cloning
or other experimental artifacts; however, four inde-
pendent candidate sequences belong to the same
H-InvDB cluster, which minimizes the probability
of cloning or experimental artifacts.
We looked for evidence that the TSRs were
actually transcribed. Using UCSC BLAT [35], each
TSR was mapped back onto the human genome,
and, using the UCSC Genome Browser, we identi-
fied annotated genes in the TSRs’ genomic regions.
Considering the 16 TSRs in Table 3, we arrived at
two distinct cases: (i) 12 TSRs were mapped onto
known gene loci (Figure 2 shows TSRs mapped
onto exons, and Figure 3, TSRs mapped onto
introns); (ii) four TSRs (actually, there is only one
non-redundant TSR) were mapped onto a Human
Endogenous Retrovirus (HERV-K) genomic region
(Figure 4).
For example, the transcript with accession
number [DDBJ:AK124366] is almost completely
mapped onto chromosome 8. However, part of its
50UTR came from chromosome 5, and it belongs to
the 30UTR of an antisense gene (PPP2CA), the acces-
sion number of which is [GenBank:NM_002715].
This sense/antisense transcript pattern resembles the
trans-splicing mechanism mediated by repetitive
sequences [16]. We developed ad hoc software to
Table 1: H-InvDB trans-splicing candidate transcripts
AC TSR 50UTR CDS 30UTR mRNA Tissue
[DDBJ:D26155] (hsNF2a) [1^293] 297 4719 241 5257 Brain
[DDBJ:AL834489] (DKFZp434F1431) [1^322] 324 1056 2367 3747 Testis
[DDBJ:AB023216] (KIAA0999) [1^302] 437 3792 231 4460 Brain
[DDBJ:AK124366] (FLJ42375 fis) [1^224] 302 255 2047 2604 Uterus
[DDBJ:AK226066] (LAMP2) [1^342] 539 1236 2333 4108 Brain
[DDBJ:AF003522] (Delta mRNA) [8^249] 322 2172 668 3162 N/A
[DDBJ:L33075] (IQGAP1) [3^400] 467 4974 2132 7573 Placenta,liver
[DDBJ:AK130557] (FLJ27047 fis) [1^578] 678 1065 1118 2861 Salivary gland
[DDBJ:L14837] (zonula occludens ZO-1) [6^732] 1190 5247 1450 7887 N/A
[DDBJ:U09825] (acid finger protein) [1^345] 555 1620 1420 3595 Kidney clone
[DDBJ:AB007865] (KIAA0405) [1^987] 1124 1983 4420 7887 Brain
[DDBJ:AB020656] (KIAA0849) [4^233] 446 2862 2106 5414 Brain
[DDBJ:AF458052] (GRM7) [8^303] 451 2775 163 3389 a
[DDBJ:AF458053] (GRM7) [8^303] 451 2736 135 3322 a
[DDBJ:AF458054] (GRM7) [8^303] 451 2721 31 3203 a
[DDBJ:U92458] (GRM7) [8^303] 451 2748 1113 4312 Fetal brain
aBrain, trachea, testis, uterus, salivary gland.
Complete: H-InvDB trans-splicing candidate transcripts. The 16 candidate sequences are listed with the following information: accession number
(AC),TSR, 50 - and 30 -UTR,CDS, messenger ribonucleic acid transcript (mRNA) length in base pairs (bp) and tissue origin (N/A indicates that this
informationwas not available).


















Figure 2: Gene structure (50UTR-CDS-30UTR, including the corresponding number of base pairs) of six trans-spli-
cing candidates mapped onto exons from a different transcript. Each transcript from (a) to (f) has an annotated
chromosome number, which is transcribed to generate one of our candidate transcripts formed by a TSR in its
50UTR region. This region is transcribed by a different chromosome, within a single exon (belonging to a UTR)
from another transcript. Arrows indicate the transcript and the chromosome orientation, in sense or antisense.
Table 2: Splice sites from candidate sequences
AC Locus TSR
Chr
TSR Sp CDS-30UTR Sp
[DDBJ:D26155] 9p24.3 6 AA-TSR-TT AG-CDS-30UTR
[DDBJ:AL834489] 5q35.2 12 GG-TSR-AG CG-CDS-30UTR
[DDBJ:AB023216] 11q23.3 2 CG-TSR-GC CT-CDS-30UTR
[DDBJ:AK124366] 8q24.12 5 CT-TSR-CA TG-CDS-30UTR
[DDBJ:AK226066] Xq24 1 GT-TSR-AT CT-CDS-30UTR
[DDBJ:AF003522] 6q27 14 TT-TSR-AG TC-CDS-30UTR
[DDBJ:L33075] 15q26.1 4 CT-TSR-TC CA-CDS-30UTR
[DDBJ:AK130557] 4q13.3 19 AT-TSR-TA TT-CDS-30UTR
[DDBJ:L14837] 15q13.1 16 TT-TSR-AC GC-CDS-30UTR
[DDBJ:U09825] 6p21.33 1 AA-TSR-AA CA-CDS-30UTR
[DDBJ:AB007865] 14q31.3 4 GA-TSR-TT CC-CDS-30UTR
[DDBJ:AB020656] 16q12.1 11 GG-TSR-AG TC-CDS-30UTR
[DDBJ:AF458052] 3p26.1 19 CA-TSR-TT CT-CDS-30UTR
[DDBJ:AF458053] 3p26.1 19 CA-TSR-TT CT-CDS-30UTR
[DDBJ:AF458054] 3p26.1 19 CA-TSR-TT CT-CDS-30UTR
[DDBJ:U92458] 3p26.1 19 CA-TSR-TT CT-CDS-30UTR
Complete: Candidate sequence splicing sites. The first column
contains the candidate sequence AC followedby its chromosomalmap
location (locus), trans-spliced chromosome region (TSR Chr), splicing
site dinucleotides in bold letters (TSR Sp) and (CDS-30UTR Sp),
respectively.
Table 3: TSR associated transcripts
AC AT
[DDBJ:D26155] [GenBank:NM_020823] (TMEM181) [Exon: 1^293]
[DDBJ:AL834489] [GenBank:NM_175736] (FMNL3) [Exon: 106^322]
[DDBJ:AB023216] [GenBank:NM_016552] (ANKMY1) [Exon: 110^218]
[DDBJ:AK124366] [GenBank:NM_002715] (PPP2CA) [Exon: 1^224]
[DDBJ:AK226066] [GenBank:NM_001821] (CHML) [Exon: 1^342]
[DDBJ:AF003522] [GenBank:NM_021136] (RTN1-1) [Exon: 1^242]
[DDBJ:L33075] [GenBank:BC032784] (CAMK2D) [Intron]
[DDBJ:AK130557] [GenBank:BC136777] (ZNF700) [Intron]
[DDBJ:L14837] [GenBank:AK124977] (FLJ42987 fis) [Intron]
[DDBJ:U09825] [GenBank:NM_025106] (SPSB) [Intron]
[DDBJ:AB007865] [GenBank:NM_147182] (KCNIP4) [Intron]
[DDBJ:AB020656] [GenBank:BC030148] (ARFGAP2) [Intron]
[DDBJ:AF458052] [GenBank:Q9YNA8] (HERV-K) ^ 19q12
[DDBJ:AF458053] [GenBank:Q9YNA8] (HERV-K) ^ 19q12
[DDBJ:AF458054] [GenBank:Q9YNA8] (HERV-K) ^ 19q12
[DDBJ:U92458] [GenBank:Q9YNA8] (HERV-K) ^ 19q12
Complete: TSR associated transcripts. When the TSR was mapped
onto known genes (in bold), either it was mapped onto exons or onto
introns (indicated in brackets). The corresponding gene codes are in
parentheses.


















Figure 3: Gene structure (50UTR-CDS-30UTR, including the corresponding number of base pairs) of six trans-
splicing candidates mapped onto the introns from a different transcript. Each transcript from (a) to (f) has an anno-
tated chromosome, which is transcribed to generate one of our candidate transcripts that are formed by aTSR in
its 50UTR region. This region is transcribed by a different chromosome, within a single intron (in UTR or CDS)
from another transcript. Arrows indicates the transcript and the chromosome orientation, in sense or antisense.
Figure 4: TSR from transcript [DDBJ:AF458052] mapped onto chromosome19.On the left, the gene structure and
its parts mapped onto chromosomes 3 (sense) and19 (antisense).On the right,GenMark (genomic sequence analysis
considering 100kbp up-and-down stream of the TSR.) predicted genes which are highly similar to Human
Endogenous RetroVirus (HERV-K).


















look for short, inverted repeats that could mediate
the trans-splicing event in both mRNA genomic
regions. Although we found several almost perfect
inverted repeats in all cases, in order to visualize
some examples, we considered only those inverted
repeats with at least 250 bp and with high sequence
identity (Figure 5). We can see that, in some cases,
there are so many inverted repeats that it is difficult
to interpret the graphical representation. It is worth
noting that most of the inverted repeats identified
are actually Alu repeats.
The TSRs that were mapped onto a HERV-K
genomic region are the most interesting and deserve
special discussion. The UCSC Genome Browser
indicated only LINE elements in the TSRs’ locus.
In order to confirm the presence of an active tran-
script, using BLAT, we mapped these TSRs onto
the human genome, with the aim of obtaining
expanded sequences (considering 100 kbp up- and
down-stream of each mapped sequence). Applying
validated gene prediction software, GeneMark [36],
we found several putative amino acid sequences,
some of which were actually similar to the retrovirus
structure (gag-pol-env), in this case, the Human
Endogenous Retrovirus K (HERV-K), which is an
active human endogenous retrovirus active in the
human organism [37]. We acknowledge that this
is not strong evidence of transcription, because the
information that HERV-K is an active mobile
genetic element may suggest that the TSR is actually
transcribed. However, as we are considering the
reference genome only and HERV-K is a repetitive
sequence, it is also possible that a new insertion has
occurred which placed it into the existing gene, in
which case, we would have no trans-splicing event
at all. Nevertheless, as will be discussed below,
two independent laboratories have indentified this
hybrid mRNA. Thus, either a new insertion in the
existing gene has occurred or a trans-splicing event




The sequences [DDBJ:AF458052], [DDBJ:
AF458053], [DDBJ:AF458054] and [DDBJ:
U92458] belong to the same H-InvDB cluster
(number HIX0019725). This cluster has four more
sequences that do not have trans-splicing characteris-
tics. The four independent candidate sequences have
the same trans-splicing pattern (Table 4), which is an
unusual finding. Sequence [DDBJ:U92458] was
obtained from a human fetal brain and was reported
in 1998 by a Lilly Research Centre group in the
USA [38], while sequences [DDBJ:AF458052],
[DDBJ:AF458053] and [DDBJ:AF458054] were
obtained from several human tissues, and were
deposited in 2002 by the Human Genetics group
at the University of Wuerzburg, Germany [39].
This cluster is associated with GPCR, family 3,
a metabotropic glutamate receptor-like gene family.
Their TSRs are mapped onto chromosome 19 (asso-
ciated with HERV-K), while the remaining sequence
is mapped onto chromosome 3. Their 50UTR
sequence has 451 bp, where the initial 303 bp form
the TSR. However, only 296 bp from the TSR
sequence were successfully mapped onto chromo-
some 19. The initial 7 bp were missing. Its TSR
belongs to a well studied human endogenous retro-
virus (HERV-K). These retrovirus’ transcripts are
found in every human tissue and they are still
active. Unfortunately, the fact that HERV-K is
still an active mobile element may jeopardize the
hypothesis of trans-splicing event, because it is
equally possible that a new insertion has occurred
which placed the HERV-K into the GPCR geno-
mic region in chromosome 3. Further investigation
is required in order to decide which phenomenon
has actually occurred.
Assuming that no new HERV-K insertion
has occurred and considering the rarity of the trans--
splicing phenomenon, the occurrence of four
instances of candidate sequences in the same cluster
is surprising for two reasons: first, because the
sequences were deposited by two independent
groups, implying that this phenomenon is recurrent
and specific; second, considering the full length
cDNA construction library methodology, the prob-
ability of laboratorial artifacts is reduced considerably.
A representative case: FLRT2
There is a single candidate sequence, accession
number [DDBJ:AB007865], that most resembles
the ACAT-1 trans-splicing pattern [29]. It is a
human fibronectin leucine-rich transmembrane pro-
tein 2 (FLRT2) [40], the transcript structure of which
is depicted in Figure 6. This transcript belongs to
the H-InvDB Cluster HIX0011865, which contains
six FLcDNA sequences of the FLRT2 gene, but only
sequence HIT00000122 (AC [DDBJ:AB007865])


















might be an interchromosomal trans-splicing candi-
date (Figure 7).
All CDS and 30UTRs were successfully mapped
onto chromosome 14 (location 14q31.3) with high
identity and coverage scores. The chromosome 14
assemblage has been completed [41], i.e. a single
continuous segment with no gaps; there are 87 410
661 bps, representing its whole euchromatic portion
in a single scaffold. The sequence HIT00000122
is the longest one in the H-InvDB Cluster
Figure 5: From (a) to (g) we show the alignments between candidate sequences and their associated transcripts
(transcripts containing the TSR). For better visualization, only those alignments with at least 250bp are shown.
The majority of these repetitive sequences are actually Alu-like repeats.
Table 4: H-InvDB HIX0019725 cluster transcripts
AC HIT Tissue 50UTR CDS 30UTR
[DDBJ:AF458052] (GRM7) HIT000079970 a 451 2775 163
[DDBJ:AF458053] (GRM7) HIT000079971 a 451 2736 135
[DDBJ:AF458054] (GRM7) HIT000079972 a 451 2721 31
[DDBJ:U92458] (GRM7) HIT000222625 Fetal brain 451 2748 1113
aBrain, trachea, testis, uterus, salivary gland.
Complete: H-InvDB cluster HIX0019725 transcripts. For each transcript, AC, identification in H-Inv (HIT), tissue origin,
and the size of 50UTR,CDS and 30UTR.


















HIX0011865, with 7527 nucleotides. Its tissue origin
is brain, with 1124 and 4420 nucleotide-long 50UTR
and 30UTR sequences, respectively. Exactly 987
nucleotides from 50UTR have been mapped onto
chromosome 4 with high (100%) identity, and no
other part of it was found in other chromosomes.
As reported earlier, its TSR was found within an
intron belonging to an antisense gene (KCNIP4).
CONCLUSION
In this work, we have shown a methodology for
searching for hybrid mRNAs, the characteristics of
which most resemble those of the best experimental
assay. For illustrative purposes, we used a curated
human FL-cDNA database, selected filtering criteria
that were supported by experimental evidence, and
we successfully found 16 human hybrid mRNAs. It
is worth noting that in humans, except in a single
case, the interchromosomal trans-splicing mechanism
does not follow consensus splicing site rules similar
to the standard cis-splicing mechanism; however,
these rules have been extensively applied in other
screening methodologies, which partially explains
why none of our candidates had been previously
identified.
Figure 6: FLRT2 interchromosomal trans-splicing transcript structure.The 50UTR has 987bp that are trans-spliced
from chromosome 4.The remaining sequence belongs to chromosome 14.
Figure 7: Cluster HIX0011865 transcripts.The transcript structure is shown. At the top, we show the six mRNAs
and their 50 -UTR, CDS and 30 -UTR. At the bottom, the same set of genes and the sizes of each region considering
exon^intron structures.


















This result may indicate that trans-splicing,
although rare, may be more widespread than
believed. Given that none of our candidate
sequences follows canonical splicing sites, either
infrequent splicing sites occur under special condi-
tions or a non-spliceosome-mediated trans-splicing
mechanism may be involved, such as the recently
reported tRNA-mediated trans-splicing mechanism.
Moreover, both genomic regions of the candidate
sequences and their associated transcripts have
complementary inverted repeats (predominantly
Alu elements) that might be involved in a possible
non-spliceosome-mediated trans-splicing mechanism,
as conjectured in ref. [26].
Our trans-splicing candidate sequences are sup-
posedly from normal tissues, and a recent study
[42] has reported that trans-splicing may occur not
only in malignant tissues, but in normal tissues
as well, which is in agreement with our in silico
findings.
Finally, despite the fact that our methodology
was developed using human data, it can also be
applied to other organisms, and the choice of
50UTR to search for trans-splicing events, although
supported by experimental assays, was intended for
illustrative purposes only. It is clear that trans-splicing
events may also occur in CDS or 30UTR, and our
methodology is intended to deal with these cases
as well.
Key Points
 Trans-splicing may be mediated by tRNA without the spliceo-
some machinery, which means that non-canonical splicing
sitesmay occur.
 Trans-splicing is not only present in malignant tissues, but in
normal tissues as well.
 A screening pipeline may be easily applied to other databanks
to search for trans-splicing candidates in other organisms.
 The bioinformatics methodologies published so far did not
take these findings into account, which partially explains why
none of our candidate sequences was reported earlier.
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